|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52,700.00 KRW | -1.31% |
|
+7.01% | +10.95% |
| 24/12 | Deals of the day-Mergers and acquisitions | RE |
| 24/12 | South Korean court rejects bid to block Korea Zinc share sale funding US smelter | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.6 | -0.32 | 0.76 | -1.86 | -1.78 | |||||
Return on Total Capital | 0.74 | -0.41 | 0.95 | -2.24 | -2.16 | |||||
Return On Equity % | 2.3 | 4.47 | 10.01 | -1.92 | -7.93 | |||||
Return on Common Equity | 4.03 | 3.66 | 9.96 | -1.58 | -6.81 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 5.21 | 3.48 | 4.92 | -0.71 | -1.55 | |||||
SG&A Margin | 3.59 | 4.07 | 3.22 | 3.56 | 3.88 | |||||
EBITDA Margin % | 5.95 | 2.16 | 4.32 | -0.48 | -0.49 | |||||
EBITA Margin % | 1.51 | -0.72 | 1.58 | -4.49 | -5.73 | |||||
EBIT Margin % | 1.47 | -0.75 | 1.55 | -4.51 | -5.76 | |||||
Income From Continuing Operations Margin % | 2.68 | 4.75 | 9.38 | -2.22 | -11.76 | |||||
Net Income Margin % | 4.17 | 3.47 | 8.29 | -1.62 | -9.05 | |||||
Net Avail. For Common Margin % | 4.17 | 3.47 | 8.29 | -1.62 | -9.05 | |||||
Normalized Net Income Margin | 5.38 | 2.25 | 3.05 | 0.81 | -0.94 | |||||
Levered Free Cash Flow Margin | 3.79 | -5.64 | -2.77 | 0.74 | -5 | |||||
Unlevered Free Cash Flow Margin | 3.9 | -5.55 | -2.64 | 1.06 | -4.46 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.65 | 0.68 | 0.78 | 0.66 | 0.49 | |||||
Fixed Assets Turnover | 3.56 | 4.06 | 4.54 | 3.82 | 3.53 | |||||
Receivables Turnover (Average Receivables) | 7.72 | 8.29 | 9.3 | 8.74 | 8.53 | |||||
Inventory Turnover (Average Inventory) | 6.17 | 5.68 | 6.13 | 6.86 | 5.41 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2 | 1.83 | 1.89 | 1.99 | 1.68 | |||||
Quick Ratio | 1.35 | 1.11 | 1.16 | 1.34 | 0.99 | |||||
Operating Cash Flow to Current Liabilities | 0.34 | 0.05 | 0.37 | 0.48 | 0.02 | |||||
Days Sales Outstanding (Average Receivables) | 47.4 | 44.02 | 39.25 | 41.76 | 42.9 | |||||
Days Outstanding Inventory (Average Inventory) | 59.35 | 64.27 | 59.52 | 53.18 | 67.71 | |||||
Average Days Payable Outstanding | 36.3 | 36.96 | 36.87 | 32.84 | 28.19 | |||||
Cash Conversion Cycle (Average Days) | 70.46 | 71.33 | 61.9 | 62.09 | 82.42 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 7.32 | 9.52 | 8.74 | 9.92 | 15.42 | |||||
Total Debt / Total Capital | 6.82 | 8.7 | 8.04 | 9.02 | 13.36 | |||||
LT Debt/Equity | 0.16 | 1.09 | 4.41 | 5.64 | 5.99 | |||||
Long-Term Debt / Total Capital | 0.15 | 0.99 | 4.05 | 5.13 | 5.19 | |||||
Total Liabilities / Total Assets | 25.77 | 29.32 | 25.01 | 23.08 | 30.1 | |||||
EBIT / Interest Expense | 8.22 | -5.67 | 7.67 | -8.99 | -6.59 | |||||
EBITDA / Interest Expense | 33.22 | 16.3 | 21.29 | -0.96 | -0.56 | |||||
(EBITDA - Capex) / Interest Expense | 14.55 | -13.88 | -14.38 | -8.92 | -4.92 | |||||
Total Debt / EBITDA | 1.43 | 4.81 | 2.01 | -23.34 | -44.69 | |||||
Net Debt / EBITDA | -1.91 | -2.96 | -0.53 | 3.19 | -4.19 | |||||
Total Debt / (EBITDA - Capex) | 3.28 | -5.64 | -2.98 | -2.52 | -5.13 | |||||
Net Debt / (EBITDA - Capex) | -4.36 | 3.47 | 0.78 | 0.34 | -0.48 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 3.22 | 12.52 | 23.66 | -15.08 | -25.9 | |||||
Gross Profit, 1 Yr. Growth % | -23 | -24.88 | 75.1 | -112.32 | 61.32 | |||||
EBITDA, 1 Yr. Growth % | -25.26 | -59.16 | 147.25 | -109.52 | -24.45 | |||||
EBITA, 1 Yr. Growth % | -43.19 | -153.52 | -371.47 | -341.91 | -5.44 | |||||
EBIT, 1 Yr. Growth % | -43.9 | -157.45 | -355.75 | -346.74 | -5.46 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -58.85 | 99.26 | 144.36 | -120.06 | 293.2 | |||||
Net Income, 1 Yr. Growth % | -43.08 | -6.38 | 195.7 | -116.58 | 314.28 | |||||
Normalized Net Income, 1 Yr. Growth % | -11.12 | -52.88 | 67.5 | -77.47 | -185.78 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -43.08 | -6.38 | 195.7 | -116.58 | 314.28 | |||||
Accounts Receivable, 1 Yr. Growth % | -0.72 | 10.35 | 10.14 | -27.59 | -19.25 | |||||
Inventory, 1 Yr. Growth % | 7.02 | 40.64 | -6.99 | -33.2 | 36.93 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -6.29 | 3.95 | 16.71 | -12.41 | -28.65 | |||||
Total Assets, 1 Yr. Growth % | 3.48 | 10.4 | 6.36 | -5.17 | 2.4 | |||||
Tangible Book Value, 1 Yr. Growth % | 1.94 | 4.22 | 13.02 | -2.46 | -5.86 | |||||
Common Equity, 1 Yr. Growth % | 1.99 | 4.2 | 12.96 | -2.46 | -5.88 | |||||
Cash From Operations, 1 Yr. Growth % | 20.57 | -79.54 | 521.42 | -3.85 | -95.65 | |||||
Capital Expenditures, 1 Yr. Growth % | 23.19 | 34.55 | 123.71 | -53.09 | -29.49 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 13.57 | -267.55 | -39.21 | -122.76 | -599.19 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 8.66 | -260.35 | -41.13 | -133.92 | -412.6 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.51 | 7.77 | 17.96 | 2.48 | -20.67 | |||||
Gross Profit, 2 Yr. CAGR % | 429.78 | -23.95 | 14.69 | -53.56 | -55.43 | |||||
EBITDA, 2 Yr. CAGR % | 71.11 | -44.75 | 0.49 | -51.49 | -73.18 | |||||
EBITA, 2 Yr. CAGR % | -33.17 | -44.86 | 20.54 | 156.26 | 51.25 | |||||
EBIT, 2 Yr. CAGR % | -34.49 | -43.23 | 21.22 | 151.2 | 52.73 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 35.86 | -9.45 | 120.66 | -29.98 | -11.18 | |||||
Net Income, 2 Yr. CAGR % | 9.45 | -27 | 66.38 | -29.99 | -17.13 | |||||
Normalized Net Income, 2 Yr. CAGR % | 26.35 | -35.29 | -11.16 | -38.57 | -56.04 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 9.45 | -27 | 66.38 | -29.99 | -17.13 | |||||
Accounts Receivable, 2 Yr. CAGR % | 16.18 | 4.67 | 10.24 | -10.7 | -23.53 | |||||
Inventory, 2 Yr. CAGR % | -4.52 | 22.68 | 14.37 | -21.18 | -4.36 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -8.96 | -1.3 | 10.15 | 1.11 | -20.95 | |||||
Total Assets, 2 Yr. CAGR % | 2.92 | 6.88 | 8.36 | 0.43 | -1.46 | |||||
Tangible Book Value, 2 Yr. CAGR % | 4.58 | 3.08 | 8.53 | 4.99 | -4.18 | |||||
Common Equity, 2 Yr. CAGR % | 4.5 | 3.09 | 8.49 | 4.97 | -4.19 | |||||
Cash From Operations, 2 Yr. CAGR % | 40.84 | -50.33 | 12.75 | 144.44 | -79.56 | |||||
Capital Expenditures, 2 Yr. CAGR % | -2.86 | 28.75 | 73.5 | 2.44 | -42.49 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 5.96 | 37.94 | 0.92 | -62.81 | 6.58 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 4.06 | 32 | -2.84 | -55.31 | 2.98 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -5.1 | 6.43 | 12.83 | 5.72 | -8.02 | |||||
Gross Profit, 3 Yr. CAGR % | -16.29 | 176.26 | 0.43 | -45.48 | -29.67 | |||||
EBITDA, 3 Yr. CAGR % | -15.16 | 6.14 | -8.95 | -54.19 | -43.77 | |||||
EBITA, 3 Yr. CAGR % | -33.11 | -37.94 | -6.19 | 52.05 | 83.81 | |||||
EBIT, 3 Yr. CAGR % | -33.51 | -37.29 | -6.24 | 53.62 | 81.37 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -32.07 | 54.36 | 26.07 | -0.78 | 24.45 | |||||
Net Income, 3 Yr. CAGR % | -18.45 | 3.9 | 16.36 | -22.87 | 26.63 | |||||
Normalized Net Income, 3 Yr. CAGR % | -1.61 | -9.05 | -11.15 | -43.77 | -31.34 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -18.45 | 3.9 | 16.36 | -22.87 | 26.63 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.43 | 14.2 | 6.46 | -4.17 | -13.65 | |||||
Inventory, 3 Yr. CAGR % | -2.89 | 8.64 | 11.86 | -4.4 | -5.25 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -8.04 | -4.84 | 4.37 | 2.05 | -9.98 | |||||
Total Assets, 3 Yr. CAGR % | 1.35 | 5.35 | 6.71 | 3.65 | 1.08 | |||||
Tangible Book Value, 3 Yr. CAGR % | 3.9 | 4.46 | 6.29 | 4.74 | 1.24 | |||||
Common Equity, 3 Yr. CAGR % | 3.84 | 4.4 | 6.28 | 4.71 | 1.22 | |||||
Cash From Operations, 3 Yr. CAGR % | 10.1 | -25.97 | 15.3 | 6.92 | -36.2 | |||||
Capital Expenditures, 3 Yr. CAGR % | -37.15 | 8.28 | 54.78 | 12.19 | -9.55 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -27.99 | 23.45 | 4.97 | -38.57 | -11.61 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -26.85 | 20.19 | 0.85 | -31.58 | -14.53 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4.01 | 6.18 | 3.53 | 4.83 | -2 | |||||
Gross Profit, 5 Yr. CAGR % | 8.55 | 3.66 | -5.05 | 35.38 | -27.43 | |||||
EBITDA, 5 Yr. CAGR % | -3.22 | -14.16 | -9.21 | -22.4 | -44.16 | |||||
EBITA, 5 Yr. CAGR % | 62.75 | 53.39 | -15.34 | 9.44 | 13.56 | |||||
EBIT, 5 Yr. CAGR % | 53.23 | 44.78 | -15.46 | 9.24 | 13.97 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -1.04 | 5.95 | 8.82 | 12.51 | 9.59 | |||||
Net Income, 5 Yr. CAGR % | 0.57 | -5.22 | 8.46 | -11.28 | 1.59 | |||||
Normalized Net Income, 5 Yr. CAGR % | 6.43 | -10.82 | -5.55 | -22.26 | -32.95 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 0.57 | -5.22 | 8.46 | -11.28 | 1.59 | |||||
Accounts Receivable, 5 Yr. CAGR % | 8.59 | 7.13 | 4.24 | 3.5 | -6.74 | |||||
Inventory, 5 Yr. CAGR % | 8.1 | 10.3 | 3.68 | -4.45 | 5.07 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -3.26 | -0.88 | -1.16 | -2.51 | -6.61 | |||||
Total Assets, 5 Yr. CAGR % | 4.63 | 5.95 | 4.1 | 3.35 | 3.36 | |||||
Tangible Book Value, 5 Yr. CAGR % | 5.21 | 4.95 | 5.73 | 4.67 | 1.97 | |||||
Common Equity, 5 Yr. CAGR % | 5.18 | 4.91 | 5.68 | 4.63 | 1.96 | |||||
Cash From Operations, 5 Yr. CAGR % | 3.49 | -10.98 | 11.15 | 19.38 | -42.28 | |||||
Capital Expenditures, 5 Yr. CAGR % | 0.41 | 12.01 | -5.66 | 5.91 | 4.17 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 1.66 | 124.23 | -17.58 | -23.6 | 5.61 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 1.32 | 89.14 | -18.05 | -19.09 | 1.7 |
- Stock Market
- Equities
- A000670 Stock
- Financials Young Poong Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















